Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C-Reference-Cited by-同舟云学术

Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C

Published:2011-08-18 Issue:3 Volume:6 Page:613-619
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Huang Jee-Fu,Huang Chao-Kuan,Yu Ming-Lung,Dai Chia-Yen,Huang Chung-Feng,Hung Wei-Wen,Yeh Ming-Lun,Hsieh Meng-Hsuan,Yang Jeng-Fu,Hsieh Ming-Yen,Lin Zu-Yau,Chen Shinn-Chern,Wu Shun-Sheng,Chuang Wan-Long

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-011-9308-5.pdf

Reference42 articles.

1. Chuang WL, Yu ML, Dai CY, Chang WY. Treatment of chronic hepatitis C in southern Taiwan. Intervirology 2006;49:99–106

2. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41–52

3. Yang JF, Lin CI, Huang JF, et al. Viral hepatitis infections in southern Taiwan: a multicenter community-based study. Kaohsiung J Med Sci 2010;26:461–469

4. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. New Engl J Med 1998;339:1485–1492

5. Yu ML, Chuang WL. Treatment of chronic hepatitis C in Asia: when East meets West. J Gastroenterol Hepatol 2009;24:336–345

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk;Scientific Reports;2015-11-25

2. Autoantibodies in chronic hepatitis C: A clinical perspective;World Journal of Hepatology;2015

3. Patterns of Interferon-Alpha–Induced Thyroid Dysfunction Vary with Ethnicity, Sex, Smoking Status, and Pretreatment Thyrotropin in an International Cohort of Patients Treated for Hepatitis C;Thyroid;2013-09

4. The presence of thyroid peroxidase antibody of IgG2 subclass is a risk factor for thyroid dysfunction in chronic hepatitis C patients;European Journal of Endocrinology;2013-05